New York, NY -- (SBWIRE) -- 12/16/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Delcath Systems, Inc (NASDAQ:DCTH), Ballard Power Systems Inc. (USA) (NASDAQ:BLDP), Molycorp Inc (NYSE:MCP), CYS Investments Inc (NYSE:CYS)
Delcath Systems, Inc (NASDAQ:DCTH) the stock opened the session at $0.24 but then moved to $0.230. At that price, the stock showed a negative performance of -6.24%. Delcath Systems, Inc. (Delcath) is a development-stage, specialty pharmaceutical and medical device company, focused on oncology, initially cancers in the liver. Delcath focuses on the development and clinical study of the Delcath chemosaturation system. The Delcath chemosaturation system allows the administration of concentrated regional chemotherapy by isolating the circulatory system of the targeted organ. Once the organ is isolated,
Will DCTH Get Buyers Even After The Recent Rally? Find Out Here
Ballard Power Systems Inc. (USA) (NASDAQ:BLDP) opened the session at $1.67 and closed the session at $1.69. The stock showed a positive performance of 3.05% in previous trading session. Ballard Power Systems Inc. (Ballard) is engaged in design, development, manufacture, sale and service of fuel cell products for a variety of applications, focusing on motive power (material handling and buses) and stationary power (back-up power and distributed generation). It is also engaged in proton exchange membrane (PEM) fuel cell development and commercialization. The Company provides engineering services for a variety of fuel cell applications. It operates in two segments: Fuel Cell Products and Material Products.
For How Long BLDP will fight for Profitability? Read This Trend Analysis report
Molycorp Inc (NYSE:MCP) opened the session at $4.60 and closed the session at $4.57. The stock showed a negative performance of -0.87% in previous trading session. Traded with volume of 2.85 million shares in the prior session and the average volume of the stock remained 5.30 million shares. The beta of the stock remained 3.25. Molycorp, Inc. provides Rare Earths and Molybdenum products to companies. The Company's rare earth products comprise of bastnasite, cerium, europium, lanthanum, neodymium, praseodymium, yttrium, and other lanthanides.
Why Should Investors Buy MCP After the Recent Fall? Just Go Here and Find Out
CYS Investments Inc (NYSE:CYS) the stock advanced 0.27% and finished the session at $7.33. Traded with volume of 2.82 million shares in the prior session and the average volume of the stock remained 2.94 million shares. The beta of the stock remained 0.24. CYS Investments, Inc. is a specialty finance company created with the objective of achieving consistent risk-adjusted investment income. The Company invests in Agency residential mortgage-backed securities (RMBS) collateralized by fixed rate single-family residential mortgage loans (typically 15, 20 or 30 years), adjustable-rate mortgage loans (ARMs), which typically have coupon rates that reset monthly, or hybrid ARMs,
Will CYS Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)